Loading organizations...
§ Private Profile · Yusong, Taejon-jikhalsi, South Korea
Biotech company developing RNA-based therapeutics for neurodegenerative diseases, focused on blood-brain barrier drug delivery.
BIORCHESTRA is a biotechnology company based in Cambridge, Massachusetts, and Daejeon, South Korea, that develops RNA-based therapeutics targeting neurodegenerative diseases such as Alzheimer's and ALS. The enterprise utilizes a proprietary drug delivery system designed to cross the blood-brain barrier and regulate microRNA via antisense oligonucleotides to provide disease-modifying treatments rather than symptom relief. Operating with an estimated 15 to 20 employees, the clinical-stage firm generated $24.3 million in revenue in 2024 and has raised over $70 million in total funding, which includes a $45 million Series C round to advance its lead clinical candidate. BIORCHESTRA is backed by institutional investors including IMM Investment, SBI Investment, and Chong Kun Dang Pharmaceutical, and maintains a strategic research and development partnership with SK Biopharmaceuticals for novel epilepsy drugs. The organization was founded in 2016 by Branden Jin-hyeob Ryu.
BIORCHESTRA has raised $45.0M across 1 funding round.
BIORCHESTRA has raised $45.0M in total across 1 funding round.
BIORCHESTRA has raised $45.0M across 1 funding round. Most recently, it raised $45.0M Series C in February 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 28, 2022 | $45M Series C | — | Chong KUN Dang Holdings, Chong KUN Dang Pharmaceutical, Daily Partners, E&venture Partners, GS Holdings, IMM Investment, LSK Investment, NH Investment & Securities, Quantum Ventures Korea, SBI Investment, Smilegate Investment, Stick Investment, Widwin Investment | Announced |
BIORCHESTRA has raised $45.0M in total across 1 funding round.
BIORCHESTRA's investors include Chong Kun Dang Holdings, Chong Kun Dang Pharmaceutical, Daily Partners, E&Venture Partners, GS Holdings, IMM Investment, LSK Investment, NH Investment & Securities, Quantum Ventures Korea, SBI Investment, Smilegate Investment, Stick Investment.